Use of radiation therapy in posttransplant lymphoproliferative disorder (PTLD) after liver transplantation

33Citations
Citations of this article
13Readers
Mendeley users who have this article in their library.

Abstract

Posttransplant lymphoproliferative disorder (PTLD) is a common and life- threatening complication of immunosuppression used to prevent rejection of solid organ and bone marrow transplants. There is no standardized treatment algorithm, but numerous management strategies are available. We describe a patient who developed a solitary lymphoproliferative lesion in the porta hepatis 9 months after orthotopic liver transplant. Following reduction in immunosuppression with no response, she was treated with involved field radiotherapy utilizing CT-based treatment planning. A partial radiographic response was obtained, and she has not developed disease in the engrafted liver or systemically. Based on the present case report, involved field radiotherapy seems to be a reasonable treatment option for patients with localized PTLD. (C) 2000 Wiley-Liss, Inc.

Cite

CITATION STYLE

APA

Koffman, B. H., Kennedy, A. S., Heyman, M., Colonna, J., & Howell, C. (2000). Use of radiation therapy in posttransplant lymphoproliferative disorder (PTLD) after liver transplantation. International Journal of Cancer, 90(2), 104–109. https://doi.org/10.1002/(SICI)1097-0215(20000420)90:2<104::AID-IJC6>3.0.CO;2-0

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free